Bristol Myers Squibb Director Derica Rice Acquires Deferred Share Units
BRISTOL MYERS SQUIBB CO
Subscribe to track BMY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Acquisition | Bristol Myers Squibb Co ($BMY)
• Insider: Derica W. Rice (Director) • Transaction Date: September 30, 2026 • Security: Deferred Share Units • Amount: 620.994 units @ $62.40 (~$38,750 total value) • Ownership Post-Transaction: 42,084.867 units • Significance: Low (Quarterly director deferred compensation)
Comprehensive Analysis
Executive Summary
On October 2, 2026, Bristol Myers Squibb Co ($BMY) filed a Form 4 disclosing that Director Derica W. Rice acquired 620.994 Deferred Share Units on September 30, 2026. The units were credited at a reference price of $62.40 per share, representing a total value of approximately $38,750.
Transaction Details
- Security: Deferred Share Units (convertible into common stock upon departure from board or predetermined date)
- Transaction Code: 'A' (Award/Grant under the 1987 Deferred Compensation Plan for Non-Employee Directors)
- Shares/Units Acquired: 620.994
- Price per Unit: $62.40
- Post-Transaction Holdings: 42,084.867 Deferred Share Units
Significance & Market Context
This transaction carries Low trading significance as it represents standard quarterly director compensation deferred into equity units rather than an open-market purchase or sale. It aligns the director's incentives with shareholders but does not signal an active discretionary trading decision.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.